News of Note—Designing a universal flu vaccine; detecting pancreatic cancer in blood

NIH scientists are testing new approaches to preventing the flu.

Making strides towards a universal flu vaccine

Scientists from the Vaccine Research Center at the NIH have discovered that by targeting the “stem” domain of the flu virus—rather than the highly variable “head” domain, as current vaccines do—they can induce a broad immune response against multiple strains of the virus. They believe the discovery, published in the journal Science Immunology, could inform efforts to develop a universal vaccine. (Science Immunology)

Detecting pancreatic cancer early


Webinar: Meet the Challenge of Complex Protein Expression

As market demand continues to rise for more potent and effective therapeutics, biologic pipelines are evolving from standard antibody formats to next-generation biologics (NGBs). In this webinar we will discuss and demonstrate application through case studies, two significant enhancements to Lonza’s GS Xceed® expression system to help address the challenges of NGBs.

Scientists at the University of Pennsylvania and the Mayo Clinic have identified two biomarkers in blood that can be used to detect the presence of pancreatic cancer. They believe their discovery could be turned into a blood test for the early detection and diagnosis of the disease in people deemed to be at high risk based on family history. (University of Pennsylvania)

New insight into HIV could yield fresh drug targets

NIH researchers have figured out that when HIV binds to the surface of a cell, it activates a protein called TMEM 16F, which allows it to infect the cells. They showed they could block this process chemically, thereby preventing the virus from invading the cell. This could lead to new drug targets in HIV, they believe. (NIH)

Suggested Articles

In mice, Kymera's lead drug promoted tumor regression, both on its own and in combination with BTK inhibitor Imbruvica.

​​​​​​​The week’s biotech news included a map of the human lung that could aid asthma drug development and a compound that thwarts rhinoviruses like colds.

A University of Pennsylvania team discovered that a protein called TOX helps determine the fate of exhausted T cells in cancer and other diseases.